Magnetic Resonance Imaging

Magnetic resonance imaging scans (MRI) done to the mother neither affect the breast milk nor breastfeeding.
The electromagnetic field and radio waves generated with this technique does not cause harmful changes in milk composition.
Immediately after this exploration is completed, breastfeeding may be resumed successfully.
Most radiology scientific societies agree that after an MRI scan is not necessary to temporarily wean the nursing baby.

The various contrast media that are gadolinium derivatives and used for explorations with Magnetic Resonance Imaging (MRI) are considered compatible with breastfeeding because they are quickly eliminated (elimination half-life of less than 2 hours). They undergo very little metabolic changes and are virtually non-absorbable orally. They are structurally very similar to each other. Some have been shown to have no or minimal excretion into the milk.

Less than 0.04% of the dose given to the mother ends just going into the milk.
Due to its low oral bioavailability, intestinal absorption should be less than 1% of the dose took by the infant.
The maximum dose received by the infant is considered less than 0.0004% of the maternal dose, which is much less than the dose administered to a newborn infant who undergoes a MRI scan.

Some authors recommend avoiding the use on lactating women of some Gadolinium contrast media that would pose a high risk for developing Systemic Nephrogenic Fibrosis, especially in the neonatal period, like gadoversetamide, and gadodiamide dimeglumine, by using instead low-risk ones like gadoterate, gadoteridol and gadobutrol.

See below the information of this related product:

• (Gadolinium-Based RMI Contrast Agents) (Safe substance and/or breastfeeding is the best option.)

See below the information of this related group:

• ATC V08C: Magnetic Resonance Imaging Contrast Media